Search

Hutchison China MediTech Ltd ADR

Abrir

SetorSaúde

13.85 -3.21

Visão Geral

Variação de preço das ações

24h

Atual

Mín

13.77

Máximo

14.31

Indicadores-chave

By Trading Economics

Rendimento

-8.9M

-8M

Vendas

3.7M

139M

P/E

Médio do Setor

144.8

55.725

Margem de lucro

-5.724

Funcionários

1,790

EBITDA

18M

4M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+17.14% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

605M

2.5B

Abertura anterior

17.06

Fecho anterior

13.85

Sentimento de Notícias

By Acuity

50%

50%

128 / 339 Ranking em Healthcare

Hutchison China MediTech Ltd ADR Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

23 de set. de 2026, 23:31 UTC

News
Social Media

Amazon.com Inc. is declining in after-market trading amid rising Treasury yields and geopolitical tensions, contributing to broader market downturns.

23 de set. de 2026, 23:31 UTC

News

BWX Technologies Inc. received a BBB investment grade credit rating from Fitch Ratings, boosting after-market trading modestly higher.

23 de set. de 2026, 23:31 UTC

Correlated Moves
News
Event

H.B. Fuller reported Q3 2026 net revenue of $938 million and adjusted EPS of $1.52, exceeding estimates, and traded higher in after-market hours.

23 de set. de 2026, 23:26 UTC

Social Media
News

Robinhood Markets Inc. is trading slightly higher in after-market hours, bolstered by 13 revenue streams each generating over $100 million annually and positive growth forecasts.

23 de set. de 2026, 23:25 UTC

News

Kraft Heinz Co is trading higher in after-market hours following RBC Capital Markets' "Outperform" rating and $32 price target, projecting 0.9% revenue growth by 2027.

23 de set. de 2026, 23:21 UTC

News
Social Media

Meta Platforms Inc. is trading lower after-hours despite the launch of its Muse AI personal agent, which has garnered significant social media attention.

23 de set. de 2026, 23:20 UTC

News

Goldman Sachs is selling Applied Systems, valued at up to $10 billion, as its stock moves higher in after-market trading amid active investment banking.

23 de set. de 2026, 23:20 UTC

News

DoorDash Inc plans to pay $131.5 million to settle worker underpayment allegations, with its stock trading lower in after-market hours following the announcement.

23 de set. de 2026, 23:16 UTC

News

Ethereum is trading lower, diverging from recent gains, amid rising U.S. crude oil inventories and strong economic data indicating robust private sector growth.

23 de set. de 2026, 23:15 UTC

Social Media
News

Gossamer Bio Inc has submitted a New Drug Application for seralutinib targeting pulmonary arterial hypertension, with shares advancing in after-market trading.

23 de set. de 2026, 23:15 UTC

News

Cooper Companies Inc's stock declines in after-market trading following a $30 million revenue miss in Q3, despite announcing a new global innovation hub in England.

23 de set. de 2026, 23:15 UTC

News

AutoNation Inc announced a $1 million investment in cancer research grants, with its stock advancing modestly in after-market trading following the announcement.

23 de set. de 2026, 23:11 UTC

Correlated Moves
News

The USD/SEK is advancing modestly as the U.S. dollar strengthens amid signals of potential Federal Reserve rate hikes to combat inflation.

23 de set. de 2026, 23:06 UTC

News

UPS shares are slightly higher in after-market trading amid scrutiny over the diversion of sensitive F-35 parts to Hong Kong by the Chinese government.

23 de set. de 2026, 23:06 UTC

Correlated Moves
News

Lockheed Martin's stock has gained in after-market hours following reports of the Chinese government seizing sensitive F-35 parts during shipment from Australia to the U.S.

23 de set. de 2026, 23:06 UTC

Correlated Moves
News

Wells Fargo shares are modestly higher in after-market trading following the announcement of Chief Risk Officer Derek Flowers' upcoming retirement in mid-January.

23 de set. de 2026, 23:06 UTC

Social Media
News

McDonald's is exploring menu growth opportunities for households using GLP-1 medications, with plans to reintroduce salads and grilled chicken items, gaining in after-market trading.

23 de set. de 2026, 23:05 UTC

News

Lennar Corp. announced a quarterly dividend of $0.50 per share and reported increased stake from Berkshire Hathaway, with shares trading higher in after-market hours.

23 de set. de 2026, 23:05 UTC

News

Altria Group Inc. is experiencing a decline in after-market trading amid potential regulatory changes for smoke-free nicotine products, raising concerns among public health advocates.

23 de set. de 2026, 23:05 UTC

News

PepsiCo announced a significant order for 10k electric trucks through the ZET SCALE alliance, while its stock traded roughly flat in after-market hours.

23 de set. de 2026, 23:05 UTC

News

Verizon grants $1 million to Liberty Science Center for AI initiative.

23 de set. de 2026, 23:05 UTC

News

The USD/NOK is advancing modestly as U.S. crude oil inventories rose by 2.969 million barrels, raising supply concerns affecting the Norwegian krone.

23 de set. de 2026, 23:05 UTC

News

General Mills Inc reports Q1 fiscal 2027 results with improved dollar sales and strong e-commerce growth, trading slightly higher in after-market hours.

23 de set. de 2026, 23:01 UTC

News

Regenxbio Inc. has settled patent litigation with Sarepta Therapeutics, receiving $39 million, leading to a rise in after-market trading.

23 de set. de 2026, 23:01 UTC

News

TransUnion shares are trading lower after CFO Todd Cello announced his planned departure at the end of 2026, despite reaffirmed financial guidance.

23 de set. de 2026, 23:01 UTC

Correlated Moves
News

JPMorgan Chase & Co is involved in the sale of Applied Systems, valued at up to $10 billion, and is modestly higher in after-market trading.

23 de set. de 2026, 23:01 UTC

News

AbbVie Inc. is down slightly in after-market trading, pulling back from an earlier session high, with a "Sell" rating and a price target of $191.

23 de set. de 2026, 23:01 UTC

News
Social Media

MGM Resorts International's stock is sharply lower after Barry Diller withdrew his $18 billion acquisition bid, reaffirming the company's standalone commitment.

23 de set. de 2026, 23:01 UTC

News

Arcturus Therapeutics announced positive interim Phase 2 results for ARCT-810 and unveiled its LUNAR 2.0 platform, yet the stock is trading lower in after-market hours.

23 de set. de 2026, 23:01 UTC

News

The USD/THB is advancing, reaching its highest cumulative return amid strong U.S. private sector growth, with the S&P Global Composite PMI rising to 58.4.

Comparação entre Pares

Variação de preço

Hutchison China MediTech Ltd ADR Previsão

Preço-alvo

By TipRanks

17.14% parte superior

Previsão para 12 meses

Média 16.833 USD  17.14%

Máximo 18.5 USD

Mínimo 14 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Hutchison China MediTech Ltd ADR - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

3 ratings

2

Comprar

1

Manter

0

Vender

Sentimento

By Acuity

128 / 339 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Hutchison China MediTech Ltd ADR

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.